Are you Dr. Haubrich?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 44 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 W Arbor Dr
Mail Code 8208
San Diego, CA 92103Phone+1 619-543-8080Fax+1 619-298-0177- Is this information wrong?
Summary
- Dr. Richard Haubrich, MD is a board certified internist in San Diego, California. He is currently licensed to practice medicine in California. He is a Professor at University of California San Diego School of Medicine.
Education & Training
- UMass Chan Medical SchoolFellowship, Infectious Disease, 1987 - 1990
- Scripps Mercy HospitalResidency, Internal Medicine, 1983 - 1987
- Keck School of Medicine of the University of Southern CaliforniaClass of 1983
Certifications & Licensure
- CA State Medical License 1984 - 2024
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients
- Viral Dynamics and Pharmacokinetics of Abacavir and Tenofovir Start of enrollment: 2004 Dec 07
- Optimizing Treatment for Treatment-Experienced, HIV-Infected People Start of enrollment: 2008 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 61 citationsRemdesivir treatment in hospitalized patients with COVID-19: a comparative analysis of in-hospital all-cause mortality in a large multi-center observational cohort.Essy Mozaffari, Aastha Chandak, Zhiji Zhang, Shuting Liang, Mark Thrun, Robert L. Gottlieb, Daniel R. Kuritzkes, Paul E. Sax, David A. Wohl, Roman Casciano, Paul Hodgk...> ;Clinical Infectious Diseases. 2021 Oct 1
- 2 citationsClinical management of hospitalized COVID-19 patients in the United StatesEssy Mozaffari, Aastha Chandak, Zhiji Zhang, Shuting Liang, Julie Gayle, Mark Thrun, Robert L. Gottlieb, Daniel R. Kuritzkes, Paul E. Sax, David A. Wohl, Roman Cascian...> ;Open Forum Infectious Diseases. 2021 Sep 28
- 2 citationsComparative effectiveness research in COVID-19 using real-world data: methodological considerations.Stephanie Read, Artak Khachatryan, Aastha Chandak, Roman Casciano, Paul Hodgkins, Richard Haubrich, Essy Mozaffari> ;Journal of Comparative Effectiveness Research. 2021 Aug 31
- Join now to see all
Grant Support
- Improving Antiretroviral Management For HIVNational Institute Of Allergy And Infectious Diseases2006–2012
- Clinical InvestigationNational Institute Of Allergy And Infectious Diseases2007–2011
- Assessing The Clinical Consequences Of HIV Drug ResistanceNational Institute Of Allergy And Infectious Diseases2008–2009
- ACTG A5142 Lopinavir/Ritonavir PLUS Efavirenz For HIV -1 InfectionNational Center For Research Resources2007
- ACTG A5079 Physiologic Testosterone Supplementation In HIVNational Center For Research Resources2005–2006
- ACTG A5142 Lopinavir/Ritonavir PLUS Efavirenz For HIV-1 InfectionNational Center For Research Resources2004–2006
- ACTG A5079 Physiologic Testosterone Supplements In HIVNational Center For Research Resources2004